Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Presenting a broad literature review of scholarly work in the area of Business Model Innovation, this new book analyses 50 management theories in the context of BMI to yield valuable new insights. Research on BMI is still in its infancy and has so far proved to be more than just a sub-discipline of strategy or innovation research. Exploring the field of Business Innovation demonstrates the importance of the discipline as a more specialized management research field and offers new understandings of this important subject. It presents ‘grand theories’ that will help researchers approach BMI through a different angle and describes business models as phenomena, enabling readers to understand their patterns and mechanisms. Reviewing the most important academic work on the subject over the last 15 years, the authors aim to open up the debate and inspire researchers to look at this phenomenon from new and different angles. Oliver Gassmann is a Senior Professor at the University of St. Gallen Switzerland, where he is also Director of the Institute of Technology Management. Karolin Frankenberger is an Assistant Professor at the Institute of Technology Management, University of St. Gallen, Switzerland, and head of the BMI-lab. Roman Sauer is a Research Associate at the Institute of Technology Management, University of St. Gallen, Switzerland, where he works as a consultant for the BMI lab. .

Business. --- Leadership. --- Management. --- Industrial management. --- Business and Management. --- Innovation/Technology Management. --- Business Strategy/Leadership. --- Business planning. --- Strategic planning. --- Business --- Research. --- Goal setting (Strategic planning) --- Planning, Strategic --- Strategic intent (Strategic planning) --- Strategic management --- Business enterprises --- Business plans --- Corporate planning --- Corporate strategy --- Corporations --- Strategy, Corporate --- Planning --- Business planning --- Strategic planning --- Administration --- Industrial relations --- Organization --- Ability --- Command of troops --- Followership --- Business administration --- Business management --- Corporate management --- Industrial administration --- Management, Industrial --- Rationalization of industry --- Scientific management --- Management --- Industrial organization

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It’s an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare.

Business. --- Pharmacy. --- Management. --- Industrial management. --- Health care management. --- Health services administration. --- Pharmaceutical technology. --- Pharmacy management. --- Health economics. --- Medical economics. --- Business and Management. --- Innovation/Technology Management. --- Pharmaceutical Sciences/Technology. --- Pharmacoeconomics and Health Outcomes. --- Health Care Management. --- Health Economics. --- Pharmaceutical industry --- Technological innovations. --- Medical innovations --- Economics, Medical --- Health --- Health economics --- Hygiene --- Medical care --- Medicine --- Health administration --- Health care administration --- Health care management --- Health sciences administration --- Health services management --- Health planning --- Public health administration --- Chemistry --- Drugs --- Materia medica --- Pharmacology --- Pharmaceutical laboratory techniques --- Pharmaceutical laboratory technology --- Technology, Pharmaceutical --- Technology --- Administration --- Industrial relations --- Organization --- Economic aspects --- Management --- Pharmacy --- Pharmacy administration --- Drugstores --- Health services administration --- Business administration --- Business enterprises --- Business management --- Corporate management --- Corporations --- Industrial administration --- Management, Industrial --- Rationalization of industry --- Scientific management --- Business --- Industrial organization